Stage Iiia Breast Cancer
📧 Sign up to get email alerts when something new happens for Stage Iiia Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer [NA]
This clinical trial update reports the termination of a study evaluating chemotherapy before surgery and tissue sample collection in patient…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating accelerated radiation therapy after surgery for breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer [Phase 2]
Phase 2 trial update evaluating Cu64-DOTA-trastuzumab PET imaging and biomarkers to predict response to neoadjuvant trastuzumab plus pertuzu…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 [Phase 3]
A Phase 3 extension study evaluating adjuvant treatment after neoadjuvant therapy and surgery in HER2-positive early-stage breast cancer has…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase II Study of Everolimus Beyond Progression [Phase 2]
Phase II trial evaluating Everolimus beyond progression in breast cancer was terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer [Phase 3]
Phase 3 trial comparing TX05 with Herceptin in HER2-positive early breast cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors [Phase 2]
Phase 2 trial evaluating docosahexaenoic acid (DHA) in breast cancer survivors has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy [NA]
Clinical trial update on a web-based decision aid intended to improve informed decisions for patients with early-stage breast cancer conside…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating vaccine therapy in combination with Rintatolimod and/or Sargramostim for HER2-positive breas…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer [Phase 2]
Phase 2 trial evaluating omega-3 fatty acid in treating various stages of breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update investigating carboplatin and eribulin mesylate in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab and pertuzumab or bevacizumab with combination chemotherapy in stage II–III breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy plus bevacizumab for HER2-negative breast cancer in stage II/III; the study has been terminated with r…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
A phase 2 trial evaluating carboplatin with combination chemotherapy, with or without veliparib, in patients with stage IIB–IIIC breast canc…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating lapatinib ditosylate plus trastuzumab, paclitaxel, and surgery for HER2-positive breast cancer completed with resul…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen of sunitinib, paclitaxel, doxorubicin, and cyclophosphamide in stage IIB-IIIC breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Phase 2]
Phase 2 clinical trial evaluating zoledronic acid for aromatase inhibitor-induced musculoskeletal symptoms in breast cancer patients has com…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer [NA]
This trial evaluated gene-expression-guided selection of neoadjuvant therapy for breast cancer patients before surgery, comparing hormone th…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer [Phase 1, Phase 2]
Clinical trial update on tipifarnib in combination chemotherapy for stage II/III breast cancer, including Phase 1 and Phase 2 results comple…
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant tipifarnib with docetaxel and capecitabine in adults with locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating goserelin with letrozole or anastrozole in premenopausal women with stage II-III estrogen receptor-positive breast …
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer [Phase 1]
Phase 1 trial evaluating RO4929097 in combination with letrozole for postmenopausal women with estrogen receptor-positive, HER2-negative bre…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating the three-drug combination of tipifarnib, doxorubicin, and cyclophosphamide in women with locally advanced breast c…